PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
15-Oct-2025 Northwell Showcases New Field of Medicine at Constellation Forum 2025 Businesswire
15-Oct-2025 ADOCIA Reports Third Quarter 2025 Financial Results and Provides a Business Update Businesswire
15-Oct-2025 Liberate Bio Demonstrates First In Vivo CAR-M–Mediated B-Cell Depletion in Non-Human Primates Businesswire
15-Oct-2025 Meharry Medical College's GREAT Health Study Launches on Vibrent Platform, Marks New Era in Community-Embedded, Genomic Research Businesswire
15-Oct-2025 ClearB Therapeutics Announces Sentinel Safety Outcome and Opening of the Remainder of the Cohort in a Phase 1b First in Human Study of CLB-4000 for the Treatment of Chronic Hepatitis B Infection Businesswire
15-Oct-2025 AI in Oncology Market Industry Trends and Forecasts Report 2025-2035, with Profiles of Berg, CancerCenter.AI, Concert AI, GE Healthcare, IBM Watson Health, iCAD, JLK Inspection, Path AI, and More - ResearchAndMarkets.com Businesswire
15-Oct-2025 MilliporeSigma to Acquire Chromatography Business of JSR Life Sciences, Expanding Protein A Capabilities and Downstream Portfolio Businesswire
15-Oct-2025 Libra Therapeutics Promotes Martin Gill, Ph.D., to Chief Scientific Officer Businesswire
15-Oct-2025 RIS Rx Appoints John Driscoll as Chairman of the Board Businesswire
15-Oct-2025 Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents Businesswire
15-Oct-2025 Owlet™ Secures CDSCO Approval for Dream Sock® and Plans 2026 Expansion into India Businesswire
15-Oct-2025 Gareth Morgan Named President of Qpex Biopharma, Inc. Businesswire
15-Oct-2025 Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Businesswire
15-Oct-2025 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
15-Oct-2025 Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption Businesswire
15-Oct-2025 Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal Businesswire
15-Oct-2025 Newleos Therapeutics CEO David Donabedian Recognized by Goldman Sachs as One of the Most Exceptional Entrepreneurs at the 2025 Builders and Innovators Summit Businesswire
15-Oct-2025 bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements Businesswire
15-Oct-2025 Real Chemistry Strengthens Media and Omnichannel Leadership with Acquisition of Spring & Bond Businesswire
15-Oct-2025 OcuSciences Secures EU CE Clearance and Expands European Presence with OcuMet Beacon Instruments Businesswire